Free Trial

MarketBeat Instant News Alerts

Axsome Therapeutics logo with Healthcare background

Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $295.00 by Analysts at Royal Bank Of Canada

Royal Bank Of Canada decreased their price objective on shares of Axsome Therapeutics from $297.00 to $295.00 and set an "outperform" rating for the company in a research report on Thursday.

NASDAQ:AXSM
Read Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $295.00 by Analysts at Royal Bank Of Canada
Cytokinetics logo with Healthcare background

Cytokinetics (NASDAQ:CYTK) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Royal Bank Of Canada lifted their price objective on shares of Cytokinetics from $112.00 to $113.00 and gave the company an "outperform" rating in a report on Thursday.

NASDAQ:CYTK
Read Cytokinetics (NASDAQ:CYTK) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Exelixis logo with Healthcare background

Exelixis (NASDAQ:EXEL) Price Target Cut to $45.00 by Analysts at Royal Bank Of Canada

Royal Bank Of Canada lowered their target price on Exelixis from $46.00 to $45.00 and set a "sector perform" rating on the stock in a research note on Thursday.

NASDAQ:EXEL
Read Exelixis (NASDAQ:EXEL) Price Target Cut to $45.00 by Analysts at Royal Bank Of Canada
Jazz Pharmaceuticals logo with Healthcare background

Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of Canada

Royal Bank Of Canada dropped their price objective on Jazz Pharmaceuticals from $299.00 to $296.00 and set an "outperform" rating for the company in a research note on Thursday.

NASDAQ:JAZZ
Read Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of Canada
BeOne Medicines logo with Healthcare background

BeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Royal Bank Of Canada increased their price objective on BeOne Medicines from $450.00 to $459.00 and gave the company an "outperform" rating in a research note on Thursday.

NASDAQ:ONC
Read BeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
FrontView REIT logo with Real Estate background

BMO Capital Markets Cuts FrontView REIT (NYSE:FVR) Price Target to $20.00

BMO Capital Markets cut their target price on shares of FrontView REIT from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Thursday.

NYSE:FVR
Read BMO Capital Markets Cuts FrontView REIT (NYSE:FVR) Price Target to $20.00

Trending News

All MarketBeat Instant News Alerts

Starbucks logo with Consumer Discretionary background

Starbucks (NASDAQ:SBUX) Sees Unusually-High Trading Volume Following Dividend Announcement

NASDAQ:SBUX
Read Starbucks (NASDAQ:SBUX) Sees Unusually-High Trading Volume Following Dividend Announcement
Ginkgo Bioworks logo with Healthcare background

Ginkgo Bioworks (NYSE:DNA) Shares Gap Down After Insider Selling

NYSE:DNA
Read Ginkgo Bioworks (NYSE:DNA) Shares Gap Down After Insider Selling
Moelis & Company logo with Finance background

Morgan Stanley Cuts Moelis & Company (NYSE:MC) Price Target to $77.00

NYSE:MC
Read Morgan Stanley Cuts Moelis & Company (NYSE:MC) Price Target to $77.00
Levi Strauss & Co. logo with Consumer Discretionary background

Levi Strauss & Co. (NYSE:LEVI) Stock Price Target Cut by Wells Fargo & Company

NYSE:LEVI
Read Levi Strauss & Co. (NYSE:LEVI) Stock Price Target Cut by Wells Fargo & Company

Lincoln International (NYSE:LCLN) Stock Price Target Cut by Morgan Stanley

NYSE:LCLN
Read Lincoln International (NYSE:LCLN) Stock Price Target Cut by Morgan Stanley
Alnylam Pharmaceuticals logo with Healthcare background

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Target Cut by Royal Bank Of Canada

NASDAQ:ALNY
Read Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Target Cut by Royal Bank Of Canada
Latham Group logo with Consumer Discretionary background

Latham Group (NASDAQ:SWIM) Stock Price Down 6.6% Following Analyst Downgrade

NASDAQ:SWIM
Read Latham Group (NASDAQ:SWIM) Stock Price Down 6.6% Following Analyst Downgrade
Marathon Petroleum logo with Energy background

Marathon Petroleum (NYSE:MPC) Stock Price Up 3.7% After Analyst Upgrade

NYSE:MPC
Read Marathon Petroleum (NYSE:MPC) Stock Price Up 3.7% After Analyst Upgrade
Levi Strauss & Co. logo with Consumer Discretionary background

Levi Strauss & Co. (NYSE:LEVI) Sees Large Volume Increase Following Earnings Beat

NYSE:LEVI
Read Levi Strauss & Co. (NYSE:LEVI) Sees Large Volume Increase Following Earnings Beat
JetBlue Airways logo with Industrials background

JetBlue Airways (NASDAQ:JBLU) Hits New 12-Month Low on Analyst Downgrade

NASDAQ:JBLU
Read JetBlue Airways (NASDAQ:JBLU) Hits New 12-Month Low on Analyst Downgrade
HF Sinclair logo with Energy background

HF Sinclair (NYSE:DINO) Sets New 12-Month High After Analyst Upgrade

NYSE:DINO
Read HF Sinclair (NYSE:DINO) Sets New 12-Month High After Analyst Upgrade
Helen of Troy logo with Consumer Discretionary background

Helen of Troy (NASDAQ:HELE) Sets New 1-Year High After Better-Than-Expected Earnings

NASDAQ:HELE
Read Helen of Troy (NASDAQ:HELE) Sets New 1-Year High After Better-Than-Expected Earnings
Howmet Aerospace logo with Industrials background

Howmet Aerospace Sees Unusually Large Options Volume (NYSE:HWM)

NYSE:HWM
Read Howmet Aerospace Sees Unusually Large Options Volume (NYSE:HWM)
Flutter Entertainment logo with Consumer Discretionary background

Wedbush Cuts Flutter Entertainment (NYSE:FLUT) Price Target to $110.00

NYSE:FLUT
Read Wedbush Cuts Flutter Entertainment (NYSE:FLUT) Price Target to $110.00
Camping World logo with Consumer Discretionary background

Camping World (NYSE:CWH) Stock Price Target Cut by KeyCorp

NYSE:CWH
Read Camping World (NYSE:CWH) Stock Price Target Cut by KeyCorp
Sarepta Therapeutics logo with Healthcare background

Royal Bank Of Canada Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price

NASDAQ:SRPT
Read Royal Bank Of Canada Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Regeneron Pharmaceuticals logo with Healthcare background

Royal Bank Of Canada Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price

NASDAQ:REGN
Read Royal Bank Of Canada Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price
Patrick Industries logo with Consumer Discretionary background

KeyCorp Cuts Patrick Industries (NASDAQ:PATK) Price Target to $100.00

NASDAQ:PATK
Read KeyCorp Cuts Patrick Industries (NASDAQ:PATK) Price Target to $100.00
Gilead Sciences logo with Healthcare background

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

NASDAQ:GILD
Read Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Biogen logo with Healthcare background

Biogen (NASDAQ:BIIB) Stock Price Target Cut by Royal Bank Of Canada

NASDAQ:BIIB
Read Biogen (NASDAQ:BIIB) Stock Price Target Cut by Royal Bank Of Canada
ACADIA Pharmaceuticals logo with Healthcare background

Royal Bank Of Canada Has Lowered Expectations for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price

NASDAQ:ACAD
Read Royal Bank Of Canada Has Lowered Expectations for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price
Leifras logo with Consumer Discretionary background

What Leifras (LFS) Said on Its Q2 Earnings Call

NASDAQ:LFS
Read What Leifras (LFS) Said on Its Q2 Earnings Call
AngioDynamics logo with Healthcare background

AngioDynamics Q1 Earnings Call Highlights

NASDAQ:ANGO
Read AngioDynamics Q1 Earnings Call Highlights
Bright Minds Biosciences logo with Healthcare background

Bright Minds Biosciences (NASDAQ:DRUG) Hits New 1-Year Low - Here's What Happened

NASDAQ:DRUG
Read Bright Minds Biosciences (NASDAQ:DRUG) Hits New 1-Year Low - Here's What Happened

Featured Articles and Offers

Alert Categories

All Alerts